Thiazolidinediones (TZDs), such as pioglitazone and rosiglitazone, which are classic PPARγ agonists, exert an antidiabetic effect through improving insulin sensitivity, whereas they may cause weight gain and fatty liver disease in patients and animals11, 12, 13, 14. The gene discussed is PPARG; the disease is fatty liver disease.